Carol J. Burt Joins IQVIA Board of Directors

DANBURY, Conn. & RESEARCH TRIANGLE PARK, N.C.–(BUSINESS WIRE)–IQVIA
(NYSE:IQV) today announced the appointment of Carol J. Burt to its board
of directors, effective today. A principal of private investment firm
Burt-Hilliard Investments for more than a decade, Burt is a former
executive officer of WellPoint, Inc. (now Anthem, Inc.), lastly as
Senior Vice President, Corporate Finance and Development, and previously
served as Senior Vice President and Treasurer of American Medical
Response. Burt also serves on the operating council and as a senior
advisor to Consonance Capital Partners.

“We are pleased that Carol has agreed to be a member of our board,” said
Ari Bousbib, chairman and CEO, IQVIA. “In addition to her deep finance
and investment experience, she has a proven track record of corporate
board participation and governance within the life sciences industry.”

Burt currently serves on the board of directors of ResMed Inc. and
WellDyneRx, LLC. She previously served on the boards of directors of
Envision Healthcare, WellCare Health Plans, Inc., Vanguard Health
Systems, Inc., and Transitional Hospitals Corporation. She’s an active
member of Women Corporate Directors and recently served as Chair of the
Fortune 1000 Working Group for the Women’s Leadership Foundation of
Colorado.

About IQVIA

IQVIA (NYSE:IQV) is a leading global provider of advanced analytics,
technology solutions and contract research services to the life sciences
industry. Formed through the merger of IMS Health and Quintiles, IQVIA
applies human data science — leveraging the analytic rigor and clarity
of data science to the ever-expanding scope of human science — to enable
companies to reimagine and develop new approaches to clinical
development and commercialization, speed innovation and accelerate
improvements in healthcare outcomes. Powered by the IQVIA CORE™, IQVIA
delivers unique and actionable insights at the intersection of
large-scale analytics, transformative technology and extensive domain
expertise, as well as execution capabilities. With more than 58,000
employees, IQVIA conducts operations in more than 100 countries.

IQVIA is a global leader in protecting individual patient privacy. The
company uses a wide variety of privacy-enhancing technologies and
safeguards to protect individual privacy while generating and analyzing
information on a scale that helps healthcare stakeholders identify
disease patterns and correlate with the precise treatment path and
therapy needed for better outcomes. IQVIA’s insights and execution
capabilities help biotech, medical device and pharmaceutical companies,
medical researchers, government agencies, payers and other healthcare
stakeholders tap into a deeper understanding of diseases, human
behaviors and scientific advances, in an effort to advance their path
toward cures. To learn more, visit www.iqvia.com.

Click
here to subscribe to Mobile Alerts for IQVIA
.

IQVIAFIN

Contacts

Tor Constantino, IQVIA Media Relations (tor.constantino@iqvia.com)
+1.484.567.6732

Andrew Markwick, IQVIA Investor Relations (andrew.markwick@iqvia.com)
+1.973.257.7144

error: Content is protected !!